Beyond Air (NASDAQ:XAIR) Posts Quarterly Earnings Results, Beats Expectations By $0.09 EPS

Beyond Air (NASDAQ:XAIRGet Free Report) posted its quarterly earnings results on Monday. The company reported ($0.15) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.09, Zacks reports. Beyond Air had a negative return on equity of 227.29% and a negative net margin of 2,369.17%. During the same period in the previous year, the firm posted ($0.50) EPS.

Beyond Air Stock Down 6.5 %

XAIR stock opened at $0.41 on Wednesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 5.76 and a quick ratio of 5.38. The stock has a market capitalization of $31.12 million, a price-to-earnings ratio of -0.29 and a beta of -0.15. The business’s fifty day moving average price is $0.42 and its two-hundred day moving average price is $0.43. Beyond Air has a fifty-two week low of $0.30 and a fifty-two week high of $2.17.

Beyond Air Company Profile

(Get Free Report)

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.

Read More

Earnings History for Beyond Air (NASDAQ:XAIR)

Receive News & Ratings for Beyond Air Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beyond Air and related companies with MarketBeat.com's FREE daily email newsletter.